According to Adamas Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is ยฃ67.19 M. In 2020 the company made a revenue of ยฃ56.73 M an increase over the revenue in the year 2019 that were of ยฃ41.63 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.